Core Insights - The investment and financing market is showing signs of recovery, with a total of 151 financing cases this week, an increase of 7 from the previous week, and a total financing amount of approximately 438.51 billion RMB, up by 353.27 billion RMB from last week [3][4]. Financing Overview - This week, 78 financing events with disclosed amounts were reported, an increase of 10 from last week. The distribution of financing amounts shows a slight shift, with 11 events under 5 million RMB, 35 events between 5 million and 10 million RMB, and 6 events between 100 million and 500 million RMB [4][6]. - Notably, there was one financing event exceeding 1 billion RMB, which decreased by one from the previous week [4]. Notable Investment Events - **Smart Grid**: State Grid New Source completed a strategic financing of 365 billion RMB, marking the largest cash fundraising record in China's state-owned asset trading history. This funding aims to enhance the development of pumped storage business and is expected to leverage over 300 billion RMB in related project investments [6][7]. - **Humanoid Robots**: Zhongqing Robot recently completed over 1 billion RMB in Pre-A++ and A1 rounds of financing, with investors including Xiaopeng Motors and JD.com. The company plans to accelerate its development pace and increase production capacity by five times [7]. - **Cloud Computing**: Yuntian Changxiang secured over 100 million USD in D round financing, aiming to enhance its AI business ecosystem and expand computing power deployment in key regions [7]. - **Artificial Heart**: Tongxin Medical completed over 100 million USD in E round financing, focusing on international expansion and product innovation [8]. Industry Distribution - The financing events this week spanned 13 industries, with the top five being Information Technology, Equipment Manufacturing, Healthcare, Electronics, and Power Equipment & New Energy, accounting for 78.80% of total financing events [12]. - In terms of financing amounts, the leading industries were Power Equipment & New Energy, Equipment Manufacturing, Healthcare, Information Technology, and Electronics, which collectively accounted for 98.47% of the total financing amount [14]. Regional Distribution - The top five regions for financing events were Jiangsu, Beijing, Guangdong, Shanghai, and Zhejiang, accounting for 69.54% of total events. In terms of financing amounts, these regions accounted for 96.10% of the total [20][21]. Financing Rounds - This week, early-stage financing (Angel and A rounds) accounted for 64.90% of the total number of financing events, while strategic financing dominated the amount, making up 83.58% of the total [24]. Investment Institutions - A total of 174 investment institutions participated in financing this week, with Beijing Guoguan leading with 4 investments. Other active institutions included Honghui Fund and Baohua Innovation Investment [29]. Exit Situation - There were 25 public exit cases this week, an increase of 3 from the previous week, including 12 equity transfers and 4 mergers and acquisitions [31][34].

1.拿下多个"全球首创"！打造全生命周期完整产品矩阵 近期，核心医疗凭借其在人工心脏领域的创新实力和技术积累，成功斩获超1亿美元D轮融资。本轮融 资由正心谷资本、社保基金中关村自主创新专项基金（由君联资本担任管理人）、阿美风险投资旗下 Prosperity7Ventures(P7)、基石资本及知名产业投资方联合领投，德联资本及联新资本跟投。新一轮融资 资金将用于原创性、颠覆性前沿技术孵化、加速创新产品开发，推动公司国际化战略布局、提升国际竞 争力，以中国创新动力，推动企业持续引领全球"人工心脏"行业发展。 据投融资市场公开数据，核心医疗的超1亿美元D轮融资是2025年至今，中国创新医疗器械领域最大规 模的市场化融资，同时也是我国人工心脏行业迄今为止金额最高的一轮融资。这不仅体现了中国及全球 顶尖投资机构对核心医疗底层技术创新的高度评价，也彰显了对公司产品管线布局、商业化和国际化战 略的深度认可。 全磁悬浮左心室辅助系统Corheart®6 根据国家心血管病中心、阜外医院披露数据显示，在核心医疗的Corheart® 6于2023年6月获批上市后， 中国LVAD近两年植入量实现翻倍增长，2017年至2024年间全 ...